Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Pharma (IGC) over the last 16 years, with Q3 2025 value amounting to -$6000.0.

  • Pharma's Change in Inventory changed N/A to -$6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$167000.0, marking a year-over-year increase of 8367.55%. This contributed to the annual value of -$180000.0 for FY2025, which is 8214.29% up from last year.
  • Latest data reveals that Pharma reported Change in Inventory of -$6000.0 as of Q3 2025.
  • In the past 5 years, Pharma's Change in Inventory ranged from a high of $322000.0 in Q1 2021 and a low of -$1.9 million during Q1 2022
  • Moreover, its 5-year median value for Change in Inventory was -$8000.0 (2023), whereas its average is -$206111.1.
  • The largest annual percentage gain for Pharma's Change in Inventory in the last 5 years was 380000.0% (2022), contrasted with its biggest fall of 68354.04% (2022).
  • Quarter analysis of 5 years shows Pharma's Change in Inventory stood at -$71000.0 in 2021, then surged by 97.18% to -$2000.0 in 2022, then skyrocketed by 1250.0% to $23000.0 in 2023, then plummeted by 434.78% to -$77000.0 in 2024, then soared by 92.21% to -$6000.0 in 2025.
  • Its Change in Inventory stands at -$6000.0 for Q3 2025, versus -$11000.0 for Q2 2025 and -$73000.0 for Q1 2025.